JP2001299730A - Plasma collecting instrument - Google Patents
Plasma collecting instrumentInfo
- Publication number
- JP2001299730A JP2001299730A JP2000120324A JP2000120324A JP2001299730A JP 2001299730 A JP2001299730 A JP 2001299730A JP 2000120324 A JP2000120324 A JP 2000120324A JP 2000120324 A JP2000120324 A JP 2000120324A JP 2001299730 A JP2001299730 A JP 2001299730A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- glass fiber
- plasma
- filter paper
- tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 claims abstract description 114
- 239000008280 blood Substances 0.000 claims abstract description 114
- 239000000463 material Substances 0.000 claims abstract description 40
- 239000003365 glass fiber Substances 0.000 claims abstract description 32
- 239000000706 filtrate Substances 0.000 claims abstract description 17
- 239000012982 microporous membrane Substances 0.000 claims description 22
- 238000001914 filtration Methods 0.000 abstract description 55
- 239000012528 membrane Substances 0.000 abstract description 11
- 210000002381 plasma Anatomy 0.000 description 29
- 238000003860 storage Methods 0.000 description 16
- 210000002966 serum Anatomy 0.000 description 11
- 230000002093 peripheral effect Effects 0.000 description 8
- 229920002492 poly(sulfone) Polymers 0.000 description 8
- 210000000601 blood cell Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- -1 and as a result Substances 0.000 description 3
- 238000002615 hemofiltration Methods 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 229920005669 high impact polystyrene Polymers 0.000 description 1
- 239000004797 high-impact polystyrene Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は採血と血液濾過を同
時に行って血漿試料を調製する器具に関するものであ
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a device for preparing a plasma sample by simultaneously performing blood collection and hemofiltration.
【0002】[0002]
【従来の技術】血液中の構成成分例えば代謝産物、蛋白
質、脂質、電解質、酵素、抗原、抗体などの種類や濃度
の測定は通常全血を遠心分離して得られる血漿または血
清を検体として行われている。ところが、遠心分離は手
間と時間がかかる。特に少数の検体を急いで処理したい
ときや、現場検査などには、電気を動力とし、遠心分離
機を必要とする遠心法は不向きである。そこで、濾過に
より全血から血漿や血清を分離する方法が検討されてき
た。2. Description of the Related Art The type and concentration of constituents in blood such as metabolites, proteins, lipids, electrolytes, enzymes, antigens and antibodies are usually measured using plasma or serum obtained by centrifuging whole blood. Have been done. However, centrifugation takes time and effort. In particular, when a small number of samples are to be processed quickly or on site, the centrifugal method using electricity and requiring a centrifuge is not suitable. Thus, methods for separating plasma and serum from whole blood by filtration have been studied.
【0003】この濾過方法には、ガラス繊維濾紙をカラ
ムに充填し、カラムの一方から全血を注入し、加圧や減
圧を行なって他方から血漿や血清を得るいくつかの方法
が公知化されている(特公昭44−14673号公報、
特開平2−208565号公報、特開平4−20885
6号公報、特公平5−52463号公報等)。[0003] For this filtration method, several methods have been known in which a column is filled with glass fiber filter paper, whole blood is injected from one side of the column, and pressure or pressure is reduced to obtain plasma or serum from the other side. (Japanese Patent Publication No. 44-14673,
JP-A-2-208565, JP-A-4-20885
No. 6, Japanese Patent Publication No. 5-52463, etc.).
【0004】しかし、全血から濾過により自動分析等に
よる測定に必要な量の血漿または血清を得る方法に関し
ては血糖など一部の項目を除いては、いまだ試行の段階
にあり、広く実用化されるに至っていない。[0004] However, the method of obtaining the amount of plasma or serum necessary for measurement by automatic analysis or the like from whole blood by filtration is still in the trial stage except for some items such as blood sugar, and has been widely put into practical use. Has not been reached.
【0005】そこで、本発明者らは先に、微量な血液で
あっても血漿や血清を効率よく分離しうる血液濾過ユニ
ットとして、濾材にガラス繊維濾紙と微多孔性膜を組み
合わせるとともに濾材の血漿出口側にシール部材を設け
て濾過材料の開口面積を狭めた血液濾過ユニットを完成
した(特開平9−196911号公報)。Therefore, the present inventors have previously developed a blood filtration unit capable of efficiently separating plasma and serum even with a small amount of blood by combining glass fiber filter paper with a microporous membrane as a filter medium, A blood filtration unit in which the opening area of the filtration material was narrowed by providing a seal member on the outlet side was completed (Japanese Patent Application Laid-Open No. 9-196911).
【0006】また、その血液入口に採血針を接続し、血
漿出口側には血漿受槽を配設したものも開発した(特開
平10−225448号公報)。[0006] A blood collection needle was connected to the blood inlet, and a plasma receiving tank was provided at the plasma outlet side (JP-A-10-225448).
【0007】一方、注射針が先端に装着され内部に血清
分離カラム又はフィルターを有する真空採血管と真空分
離血清採取管と両者を接合する接合針よりなる血液から
血清又は血漿成分を分離する器具も開発されている(特
開平4−208856号公報、特開平5−93721号
公報、特開平5−188053号公報)。On the other hand, there is also a device for separating serum or plasma components from blood, comprising a vacuum blood collection tube having a serum separation column or filter inside and a connection needle for connecting the two, and an injection needle attached to the tip. It has been developed (JP-A-4-208856, JP-A-5-93721, JP-A-5-188053).
【0008】[0008]
【発明が解決しようとする課題】本発明者らが先に開発
した血漿採取具は血漿受槽を有する血液濾過ユニットに
吸引アダプターやシリンジを接続して採血と血液濾過を
行うものであり、操作や取扱性に問題があって実用化に
はまだ不充分であった。The plasma collection tool developed earlier by the present inventors connects a suction adapter or a syringe to a blood filtration unit having a plasma receiving tank to perform blood collection and blood filtration. There was a problem in handling and it was still insufficient for practical use.
【0009】また、真空採血管と真空分離血清採取管を
接合針で接合させる器具は4部材を連結させ、3個所あ
る針の挿通を順序正しく行う必要があって操作が煩瑣で
あった。[0009] In addition, an instrument for joining a vacuum blood collection tube and a vacuum-separated serum collection tube with a joining needle requires four members to be connected and the insertion of three needles to be performed in order, and the operation is complicated.
【0010】本発明の目的は簡単な構造で容易に採血と
血液濾過を同時に行って血漿試料を調製できる器具を提
供することにある。An object of the present invention is to provide a device which can easily perform blood collection and blood filtration simultaneously with a simple structure to prepare a plasma sample.
【0011】[0011]
【課題を解決するための手段】本発明者らは上記課題を
解決するべく鋭意検討の結果、本発明者らが先に開発し
た血液濾過ユニットから血漿受槽を撤去して真空採血管
又は注射器を血液吸引源として用いるとともにこれらを
血漿受槽とすることにより採血と血液濾過を同時に行っ
て血漿試料を簡単かつ確実に調製できることを見出し
た。Means for Solving the Problems The present inventors have made intensive studies to solve the above problems, and as a result, removed the plasma receiving tank from the blood filtration unit developed earlier by the present inventors to replace the vacuum blood collection tube or syringe. It has been found that a plasma sample can be easily and reliably prepared by simultaneously performing blood collection and hemofiltration by using these as a blood suction source and using them as a plasma receiving tank.
【0012】本発明はかかる知見に基づいてなされたも
のであり、ガラス繊維濾紙と微多孔性膜よりなる血液濾
過材料とこれを収容し血液入口と濾過液出口を有するホ
ルダーよりなる血液濾過器と、該血液入口にチューブを
介して接続された採血針と、該濾過液出口にチューブを
介して接続された真空採血管又は注射器よりなる血漿採
取具に関するものである。The present invention has been made on the basis of such findings, and has been made of a blood filtering material comprising a glass fiber filter paper and a microporous membrane, and a blood filter comprising a holder containing the blood filtering material and having a blood inlet and a filtrate outlet. A blood collection needle connected to the blood inlet via a tube, and a vacuum blood collection tube or a syringe connected to the filtrate outlet via a tube.
【0013】[0013]
【発明の実施の形態】血液濾過器は、血液濾過材料が収
容され、血液入口と濾過液出口を有するものである。BEST MODE FOR CARRYING OUT THE INVENTION A blood filter contains a blood filtering material and has a blood inlet and a filtrate outlet.
【0014】血液濾過材料の種類は問わないが、本発明
の濾過材料では、その表面のみで血球をトラップするい
わゆる表面濾過材料ではなく、ガラス繊維濾紙等の厚さ
方向に浸透するに従って、初めは大きな血球成分、後に
は小さな血球成分と徐々に空隙構造にからめ、厚さ方向
に全長にわたって血球を留め除去していく、いわゆる体
積濾過材料によるものが使用される。好ましいものはガ
ラス繊維濾紙等であり、ガラス繊維濾紙に微多孔性膜を
組み合わせたものが特に好ましい。Although the type of blood filtration material is not limited, the filtration material of the present invention is not a so-called surface filtration material that traps blood cells only on its surface, but initially penetrates in the thickness direction of glass fiber filter paper or the like. A so-called volume filtration material is used, which gradually entraps a large blood cell component and later a small blood cell component in a void structure, and retains and removes blood cells over the entire length in the thickness direction. Preferred are glass fiber filter paper and the like, and a combination of a glass fiber filter paper and a microporous membrane is particularly preferred.
【0015】ガラス繊維濾紙は密度が0.02〜0.5
g/cm3程度、好ましくは0.03〜0.2程g/c
m3度、特に好ましくは0.05〜0.13g/cm3
程度で、保留粒子径が0.6〜9μm程度、特に1〜5
μm程度のものが好ましい。ガラス繊維の表面を、特開
平2−208565号公報、同4−208856号公報
に記載された様な方法で、親水性高分子で処理すること
によって濾過をより速やかに円滑に行なうことができ
る。また、ガラス繊維の表面をレクチンで処理すること
もできる。The glass fiber filter paper has a density of 0.02-0.5.
g / cm 3 , preferably about 0.03-0.2 g / c
m 3 degrees, particularly preferably 0.05 to 0.13 g / cm 3
And the retained particle diameter is about 0.6 to 9 μm, especially 1 to 5 μm.
It is preferably about μm. By treating the surface of the glass fiber with a hydrophilic polymer by a method as described in JP-A-2-208565 and JP-A-4-208856, filtration can be performed more quickly and smoothly. Further, the surface of the glass fiber can be treated with lectin.
【0016】表面を親水化されており血球分離能を有す
る微多孔性膜は、実質的に分析値に影響を与える程には
溶血することなく、全血から血球と血漿を特異的に分離
するものである。この微多孔性膜は孔径がガラス繊維濾
紙の保留粒子径より小さくかつ0.2μm以上、好まし
くは0.3〜5μm程度、より好ましくは0.5〜3μ
m程度のものが適当である。また、空隙率は高いものが
好ましく、具体的には、空隙率が約40%から約95
%、好ましくは約50%から約95%、さらに好ましく
は約70%から約95%の範囲のものが適当である。微
多孔性膜の例としてはポリスルホン膜、弗素含有ポリマ
ー膜等がある。A microporous membrane having a hydrophilic surface and capable of separating blood cells specifically separates blood cells and plasma from whole blood without substantially hemolyzing to affect the analytical value. Things. This microporous membrane has a pore size smaller than the retained particle size of the glass fiber filter paper and 0.2 μm or more, preferably about 0.3 to 5 μm, more preferably 0.5 to 3 μm.
m is appropriate. Further, the porosity is preferably high, and specifically, the porosity is about 40% to about 95%.
%, Preferably from about 50% to about 95%, more preferably from about 70% to about 95%. Examples of the microporous membrane include a polysulfone membrane and a fluorine-containing polymer membrane.
【0017】好ましい微多孔性膜はポリスルホン膜、酢
酸セルローズ膜等であり、特に好ましいのはポリスルホ
ン膜である。本発明の血液濾過材料においてはガラス繊
維濾紙が下側に配置され、微多孔性膜が上側に配置され
る。最も好ましい材料は下からガラス繊維濾紙、ポリス
ルホン膜をこの順に積層した積層体である。Preferred microporous membranes are polysulfone membranes and cellulose acetate membranes, and particularly preferred are polysulfone membranes. In the blood filtration material of the present invention, the glass fiber filter is disposed on the lower side, and the microporous membrane is disposed on the upper side. The most preferable material is a laminate in which a glass fiber filter paper and a polysulfone membrane are laminated in this order from the bottom.
【0018】本発明で用いられる濾過材料は特開昭62
−138756〜8号公報、特開平2−105043号
公報、特開平3−16651号公報等に開示された方法
に従って各層を部分的に配置された接着剤で接着して一
体化することができる。The filtration material used in the present invention is disclosed in
According to the methods disclosed in JP-A-138756-8, JP-A-2-105043, JP-A-3-16651, etc., each layer can be integrated by bonding with a partially arranged adhesive.
【0019】ガラス繊維濾紙層の厚さは、回収すべき血
漿や血清の量とガラス繊維濾紙の密度(空隙率)及び面
積から定められる。分析を乾式分析素子を用いて複数項
目行なう場合の血漿や血清の必要量は100〜500μ
lであり、ガラス繊維濾紙の密度が0.02〜0.2程
度、面積が1〜5cm2程度が実用的である。この場合
ガラス繊維濾紙層の厚さは1〜10mm程度、好ましく
は2〜8mm程度である。このガラス繊維濾紙は複数
枚、例えば2〜10枚程度、好ましくは3〜8枚程度を
積層して上記厚さとすることができる。The thickness of the glass fiber filter layer is determined by the amount of plasma or serum to be collected and the density (porosity) and area of the glass fiber filter paper. When performing multiple analysis using a dry analytical element, the required amount of plasma or serum is 100 to 500 μm.
It is practical that the glass fiber filter paper has a density of about 0.02 to 0.2 and an area of about 1 to 5 cm 2 . In this case, the thickness of the glass fiber filter layer is about 1 to 10 mm, preferably about 2 to 8 mm. This glass fiber filter paper can be laminated to a plurality of sheets, for example, about 2 to 10 sheets, preferably about 3 to 8 sheets, to have the above thickness.
【0020】微多孔性膜の厚さは0.05〜0.5mm
程度、特に0.1〜0.3mm程度でよく、通常は1枚
の微多孔性膜を用いればよい。しかしながら、必要によ
り複数枚を用いることもできる。The thickness of the microporous membrane is 0.05 to 0.5 mm
The thickness may be about 0.1 to 0.3 mm, and usually one microporous membrane may be used. However, a plurality of sheets can be used if necessary.
【0021】血液濾過材料はホルダーに入れられる。こ
のホルダーには血液入口と濾過液出口が設けられ、一般
に血液濾過材料を収容する本体と、蓋体に分けた態様で
作製される。通常は、いずれにも少なくとも1個の開口
が設けられていて、一方は血液入口として、他方は濾過
液出口として使用される。The hemofiltration material is placed in a holder. This holder is provided with a blood inlet and a filtrate outlet, and is generally manufactured in a mode in which a main body containing a blood filtering material and a lid are separated. Usually, each has at least one opening, one used as a blood inlet and the other used as a filtrate outlet.
【0022】血液濾過材料収納部の容積は、収納すべき
濾過材料の乾燥状態および検体(全血)を吸収し膨潤し
た時の総体積より大きい必要がある。濾過材料の総体積
に対して収納部の容積が小さいと、濾過が効率良く進行
しなかったり、溶血を起こしたりする。収納部の容積の
濾過材料の乾燥時の総体積に対する比率は濾過材料の膨
潤の程度にもよるが、通常101%〜400%、好まし
くは110%〜150%、更に好ましくは120%〜1
40%である。具体的には血漿や血清の必要量との関係
で定まるが0.5〜2.5ml程度、通常0.6〜2.
2ml程度である。The volume of the blood filtering material storage section must be larger than the dry state of the filtering material to be stored and the total volume when the sample (whole blood) is absorbed and swollen. If the volume of the storage part is small with respect to the total volume of the filtration material, filtration does not proceed efficiently or hemolysis occurs. Although the ratio of the volume of the storage portion to the total volume of the filter material when dried is dependent on the degree of swelling of the filter material, it is usually 101% to 400%, preferably 110% to 150%, and more preferably 120% to 1%.
40%. Specifically, it is determined depending on the required amount of plasma or serum, but is about 0.5 to 2.5 ml, usually 0.6 to 2.
It is about 2 ml.
【0023】また、ホルダーの濾過液出口側内面とこれ
に対向する血液濾過材料の面の間には血液濾過材料、通
常は微多孔性膜の密着を阻止する部材が設けることが好
ましい。この部材は濾過が血液濾過材料の全面にわたっ
て行なわれるよう血液濾過材料をホルダーの対向面から
離しておくものであり、例えば、対向面に複数、1cm
2当り1〜20個程度、通常3〜10個程度の突起を設
けるとか、濾過液出口に向かって収束する複数の突条を
設けるとかする。It is preferable to provide a member for preventing the blood filtration material, usually a microporous membrane, from adhering between the inner surface of the holder on the filtrate outlet side and the surface of the blood filtration material opposed thereto. This member separates the blood filtration material from the opposing surface of the holder so that the filtration is performed over the entire surface of the blood filtration material.
About 2 to 20 projections, usually about 3 to 10 projections per 2 are provided, or a plurality of projections converging toward the filtrate outlet are provided.
【0024】突起の形状は円柱状、角柱状、円錐状、角
錐状、円錐台状、角錐台状、キノコ形、不定形状等任意
の形状をとることができる。突起の先端は平ら又は円頭
状とすることが好ましい。突条の本数は2〜20本程
度、好ましくは3〜10本程度が適当である。突条は直
線状のほか曲線状等であってもよい。突起および突条の
先端は吸引時に全突起の血液濾過材料への接触面積が血
液濾過材料の表面積の1〜50%程度、好ましくは2〜
10%程度になるようにするのがよい。本発明の血液濾
過器で濾過される血液は少量であるので血液濾過材料と
ホルダーの対向面との間の空間部の体積は50〜500
μl程度、好ましくは100〜200μl程度になるよ
うにするのがよい。The shape of the projection can be any shape such as a column, a prism, a cone, a pyramid, a truncated cone, a truncated pyramid, a mushroom, and an irregular shape. The tip of the projection is preferably flat or circular. The number of ridges is about 2 to 20, preferably about 3 to 10. The ridge may be linear or curved. The tips of the protrusions and the ridges have a contact area of all protrusions with the blood filtration material at the time of suction of about 1 to 50% of the surface area of the blood filtration material, preferably 2 to
It is good to make it about 10%. Since the amount of blood filtered by the hemofilter of the present invention is small, the volume of the space between the blood filtration material and the opposite surface of the holder is 50 to 500.
It is good to make it about μl, preferably about 100-200 μl.
【0025】ホルダーの血液入口側にも濾過が血液濾過
材料の全面にわたって行なわれるよう空間を設けるのが
よい。これによってまず空気が血液濾過材料の全面から
吸引され、その結果、血液が全面に拡がって吸引濾過さ
れる。ホルダーの血液供給口側は濾過の際には血液濾過
材料がホルダー内壁から離隔する方向に作用するのでホ
ルダーの側壁に血液濾過材料縁部を保持してホルダーと
の間を明けるスペーサー、例えばリング状突部や数個所
の突部などを形成すればよい。蓋体の周縁部を血液濾過
材料側に突出させて、これをスペーサーとして機能させ
ることもできる。血液濾過材料とホルダーの対向面との
間の空間部の体積(血液濾過時)は100〜500μl
程度、好ましくは100〜200μl程度が適当であ
る。It is preferable to provide a space on the blood inlet side of the holder so that the filtration is performed over the entire surface of the blood filtration material. As a result, air is first sucked from the entire surface of the blood filtration material, and as a result, blood spreads over the entire surface and is filtered by suction. At the blood supply port side of the holder, when filtering, the blood filtering material acts in a direction away from the inner wall of the holder, so a spacer for holding the edge of the blood filtering material on the side wall of the holder and opening the gap with the holder, for example, a ring shape Protrusions or several protrusions may be formed. The peripheral portion of the lid may be protruded toward the blood filtration material, and may function as a spacer. The volume of the space between the blood filtration material and the opposing surface of the holder (at the time of blood filtration) is 100 to 500 μl.
The amount is preferably about 100 to 200 μl.
【0026】また、ホルダー本体には、ガラス繊維濾紙
を収容するガラス繊維濾紙収容室と、微多孔性膜を収容
する微多孔性膜収容室とを形成し、微多孔性膜収容室を
ガラス繊維濾紙収容室より大きく形成するのがよい。そ
れによって、ガラス繊維濾紙収容室において収容室の側
壁面を通って流れ込んだ全血があっても、球の漏出を阻
止できる。Further, a glass fiber filter paper storage chamber for storing glass fiber filter paper and a microporous membrane storage chamber for storing a microporous membrane are formed in the holder body, and the microporous membrane storage chamber is made of glass fiber. It is better to make it larger than the filter paper storage chamber. Thereby, even if there is whole blood flowing through the side wall surface of the storage chamber in the glass fiber filter paper storage chamber, it is possible to prevent the ball from leaking.
【0027】この微多孔性膜の大きさは、ガラス繊維濾
紙収容室より0.01mm程度以上大きいことが好まし
く、0.2mm程度以上大きいことがより好ましい。ま
た、微多孔性膜は、その周縁部が微多孔性膜収容室に載
置された状態になっており、この微多孔性膜収容室と接
触している周縁部の長さ(半径方向)は、0.05mm
程度以上が好ましく、0.1程度mm以上がより好まし
い。The size of the microporous membrane is preferably at least about 0.01 mm, more preferably at least about 0.2 mm, larger than the glass fiber filter paper storage chamber. Further, the microporous membrane has a peripheral portion mounted on the microporous membrane accommodating chamber, and the length (radial direction) of the peripheral portion in contact with the microporous membrane accommodating chamber. Is 0.05mm
And more preferably about 0.1 mm or more.
【0028】濾過ユニットは、上記本体に蓋体が取付け
られると、これらの血液入口と吸引口としても使用され
る濾過液出口を除いて全体が密閉構造になる。When the lid is attached to the main body, the entire filter unit has a sealed structure except for the blood inlet and the filtrate outlet which is also used as a suction port.
【0029】ホルダーの材料はプラスチックが好まし
い。例えば、ポリメタアクリル酸エステル、ポリエチレ
ン、ポリプロピレン、ポリエステル、ナイロン、ポリカ
ーボネート等の透明あるいは不透明の樹脂が用いられ
る。The material of the holder is preferably plastic. For example, a transparent or opaque resin such as polymethacrylate, polyethylene, polypropylene, polyester, nylon, and polycarbonate is used.
【0030】上記本体と蓋体の取付方法は、接着剤を用
いた接合、融着等如何なる手段によってもよい。この
際、上記本体と蓋体のいずれの周縁が内側に位置しても
よく、あるいは突き合わせ状態であってもよい。また、
上記本体と蓋体をネジ等の手段で組立分解ができる構造
とすることもできる。The main body and the lid may be attached by any means such as joining using an adhesive and fusion. In this case, the peripheral edge of either the main body or the lid may be located inside, or may be in an abutting state. Also,
The main body and the lid may be structured so that they can be assembled and disassembled by means such as screws.
【0031】血液濾過材料の形状に特に制限はないが、
製造が容易なように、円形とすることが望ましい。この
際、円の直径をホルダー本体の内径よりやや大きめと
し、濾過材料の側面から血漿が漏れることを防ぐことが
できる。一方、四角形にすれば作製した血液濾過材料の
切断ロスがなくなるので好ましい。Although there is no particular limitation on the shape of the blood filtration material,
A circular shape is desirable for ease of manufacture. At this time, the diameter of the circle is made slightly larger than the inner diameter of the holder main body, so that the plasma can be prevented from leaking from the side surface of the filtration material. On the other hand, it is preferable to use a square shape, since cutting loss of the produced blood filtration material is eliminated.
【0032】採血針はチューブを介して血液入口に接続
される。採血針は注射針をそのままあるいは加工して用
いることができる。血液入口元は予め接続しておいても
よく、使用の際に接続してもよい。接続手段は接着、融
着、螺着、嵌着等いかなる手段であってもよい。The blood collection needle is connected to the blood inlet via a tube. The blood collection needle can be used as it is or after processing the injection needle. The blood inlet may be connected in advance or may be connected at the time of use. The connection means may be any means such as adhesion, fusion, screwing, fitting and the like.
【0033】本発明の血漿採取具においては血液濾過の
ための減圧を真空採血管又は注射器で行う。真空採血管
は市販品を用いることができる。真空採血管への接続は
注射針を加工して接続具を作成するのがよい。注射器は
必要により注射針を取り除いて濾過液出口に接続すれば
よい。In the plasma collection device of the present invention, reduced pressure for blood filtration is performed by a vacuum blood collection tube or a syringe. A commercially available product can be used for the vacuum blood collection tube. The connection to the vacuum blood collection tube is preferably made by processing a syringe needle to make a connection device. The syringe may be connected to the filtrate outlet after removing the injection needle if necessary.
【0034】本発明の血漿採取具は、血液濾過器に接続
されている採血針を血管に挿入し、血液濾過器の濾過液
出口に真空採血管又は注射器を接続して必要量の血漿を
採取すればよい。In the plasma collection device of the present invention, a blood collection needle connected to a blood filter is inserted into a blood vessel, and a vacuum blood collection tube or a syringe is connected to a filtrate outlet of the blood filter to collect a required amount of plasma. do it.
【0035】[0035]
【実施例】本発明の一実施例である血漿採取具を図1に
示す。FIG. 1 shows a plasma collection tool according to an embodiment of the present invention.
【0036】この血漿採取具は血液濾過器1と採血針2
と真空採血管3よりなっている。This blood plasma collection tool comprises a blood filter 1 and a blood collection needle 2
And a vacuum blood collection tube 3.
【0037】この血液濾過ユニットは、図2に示すよう
に、ホルダーを有し、このホルダーは、ホルダー本体1
0と、その上部に密着固定された蓋体20とからなって
いる。This blood filtration unit has a holder as shown in FIG.
0 and a lid 20 closely adhered and fixed to the upper portion.
【0038】このホルダー本体10はハイインパクトポ
リスチレン樹脂で形成されたもので、血液濾過材料を構
成するガラス繊維濾紙31を収容するガラス繊維濾紙収
納室11が形成されるとともに、このガラス繊維濾紙収
納室11の上部において、血液濾過材料を構成する微多
孔性膜としてのポリスルホン多孔性膜32を収容する微
多孔性膜収納室12が形成されている。この微多孔性膜
収納室12は、下端においてガラス繊維濾紙収納室11
より大きい径の段部19が形成されており、この段部1
9にポリスルホン多孔性膜32が載置された状態で収容
される。また、この段部19の外周縁から、上方に斜め
に立ち上がった傾斜部13が形成されており、傾斜部1
3の上縁から外方にフランジ14が形成されている。The holder body 10 is made of a high-impact polystyrene resin. The holder body 10 has a glass fiber filter paper storage chamber 11 for storing a glass fiber filter paper 31 constituting a blood filtration material. Above the upper part 11, a microporous membrane storage chamber 12 for storing a polysulfone porous membrane 32 as a microporous membrane constituting a blood filtration material is formed. The microporous membrane storage chamber 12 has a glass fiber filter paper storage chamber 11 at the lower end.
A step 19 having a larger diameter is formed.
9, the polysulfone porous membrane 32 is accommodated in a mounted state. Further, an inclined portion 13 that rises obliquely upward from the outer peripheral edge of the step portion 19 is formed.
A flange 14 is formed outwardly from the upper edge of 3.
【0039】一方、ホルダー本体10の底部には、周縁
よりやや内側にガラス繊維濾紙載置部15を設けてそこ
から浅いロート状円板部16が連接され、このロート状
円板部16の中心から下方にノズル状血液入口17が延
設されている。このノズル状血液入口17には、血液濾
過の際真空採血管3又は注射器が装着される。上記ガラ
ス繊維濾紙載置部15は、ガラス繊維濾紙31の下面を
ホルダー本体10のロート状円板部16から隔離させて
空間18を形成するスぺーサとしても機能している。On the other hand, at the bottom of the holder body 10, a glass fiber filter paper mounting portion 15 is provided slightly inside from the peripheral edge, from which a shallow funnel-shaped disc portion 16 is connected. A nozzle-like blood inlet 17 extends downward from the nozzle. A vacuum blood collection tube 3 or a syringe is attached to the nozzle-shaped blood inlet 17 during blood filtration. The glass fiber filter paper mounting portion 15 also functions as a spacer that forms a space 18 by separating the lower surface of the glass fiber filter paper 31 from the funnel-shaped disk portion 16 of the holder body 10.
【0040】蓋体20はディスク状をしており、その周
縁は図面上方に立ち上がって壁部21を形成し、その上
端が外側に折り曲がってフランジ22を形成している。
前記壁部21は、上方へ行くに従って外側へ広がるテー
パー状に形成されており、この壁部21の傾斜角は前記
傾斜部13の傾斜角と同一であり、また、外径が傾斜部
13の内径と同一となっている。すなわち、壁部21が
傾斜部13に密着状態で嵌合するようになっている。前
記フランジ22がホルダー本体10のフランジ14と超
音波で接着されている。このフランジ22の底面(フラ
ンジ14と接着する面)には接着以前の段階において、
接着の際超音波エネルギーをそこに集めて液密性を充分
に確保した状態で接着できるように、リブが形成されて
いる(なお、接着後は溶融消滅している)。The lid 20 has a disk shape, and its peripheral edge rises upward in the drawing to form a wall 21, and its upper end is bent outward to form a flange 22.
The wall portion 21 is formed in a tapered shape that spreads outward as going upward. The inclination angle of the wall portion 21 is the same as the inclination angle of the inclined portion 13, and the outer diameter of the It is the same as the inside diameter. That is, the wall portion 21 is fitted to the inclined portion 13 in a close contact state. The flange 22 is ultrasonically bonded to the flange 14 of the holder body 10. Before bonding, the bottom surface of the flange 22 (the surface to be bonded to the flange 14)
The ribs are formed so that the ultrasonic energy is collected there during the bonding and the bonding can be performed in a state where the liquid tightness is sufficiently ensured (the bonding is melted and disappeared after the bonding).
【0041】また、蓋体20の底面には12個の突起2
6が略均等な間隔で形成されており、この突起26によ
り、ポリスルホン多孔性膜32が密着するのを防止して
いる。The bottom surface of the lid 20 has twelve projections 2
The protrusions 26 prevent the polysulfone porous membrane 32 from sticking to each other.
【0042】蓋体20はその底面形状に対応して壁部2
1の基部よりやや中央寄りから少し盛り上がっており、
中央部にはノズル状の濾過液出口23が上方に突設され
ている。The lid 20 has a wall 2 corresponding to its bottom shape.
It rises slightly from the center slightly from the base of 1,
A nozzle-shaped filtrate outlet 23 projects upward from the center.
【0043】なお、以上のような血液濾過器において、
ガラス繊維濾紙収納室11の直径は20.1mm、同深
さ5.9mm、微多孔性膜収納室12の下端における直
径23.0mm、同上端における直径22.5mm、同
深さ2.10mm、壁部21の外周面下端の直径20.
98mm、同下面からフランジ24までの高さ2mm、
ガラス繊維濾紙31の直径20.0mm、同厚さ0.9
1mmのものを6枚、ポリスルホン多孔性膜32の直径
20.9mm、同厚さ150μmである。In the above blood filter,
The diameter of the glass fiber filter paper storage chamber 11 is 20.1 mm, the depth is 5.9 mm, the diameter at the lower end of the microporous membrane storage chamber 12 is 23.0 mm, the diameter at the upper end is 22.5 mm, the depth is 2.10 mm, 20. diameter of the lower end of the outer peripheral surface of wall 21
98 mm, height 2 mm from the lower surface to the flange 24,
20.0 mm in diameter and 0.9 in thickness of glass fiber filter paper 31
Six 1 mm-thick porous polysulfone membranes 32 have a diameter of 20.9 mm and a thickness of 150 μm.
【0044】図3に真空採血管3への接続治具4を示
す。この接続治具4は真空採血管3に被嵌するキャップ
41の中央から上下両方に突出する濾過液通路42が設
けられ、その上側突出部には濾過液出口23に接続され
たチューブ43が嵌入され、下側突出部には挿通針44
が嵌入されている。使用の際にはこの接続治具4を真空
採血管3に嵌込めば挿通針44が真空採血管3の挿通部
を刺通して接続が行われる。FIG. 3 shows a connecting jig 4 for connecting to the vacuum blood collection tube 3. The connection jig 4 is provided with a filtrate passage 42 projecting upward and downward from the center of a cap 41 fitted on the vacuum blood collection tube 3, and a tube 43 connected to the filtrate outlet 23 is fitted into the upper projecting portion. The insertion needle 44 is provided at the lower protruding portion.
Is inserted. At the time of use, if the connection jig 4 is fitted into the vacuum blood collection tube 3, the insertion needle 44 pierces the insertion portion of the vacuum blood collection tube 3 to perform connection.
【0045】なお、上記真空採血管に代えて注射針を装
着していない注射器を接続しても同様に血液濾過を行っ
て血漿を採取することができる。It should be noted that even if a syringe without an injection needle is connected in place of the vacuum blood collection tube, blood filtration can be performed in the same manner to collect plasma.
【発明の効果】本発明の血漿採取具を用いることによっ
て容易に採血と血液濾過を行って必要量の血漿を得るこ
とができる。According to the present invention, a required amount of plasma can be obtained by easily performing blood collection and blood filtration by using the plasma collection device of the present invention.
【図1】 本発明の血漿採取具の一例の構成を示す斜視
図である。FIG. 1 is a perspective view showing a configuration of an example of a plasma collection tool of the present invention.
【図2】 その血液濾過器の縦断面図である。FIG. 2 is a longitudinal sectional view of the blood filter.
【図3】 真空採血管への接続治具の縦断面図である。FIG. 3 is a longitudinal sectional view of a jig for connecting to a vacuum blood collection tube.
1…血液濾過器 2…採血針 3…真空採血管 1. Blood filter 2. Blood collection needle 3. Vacuum blood collection tube
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61B 5/14 300B 300E 300F ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61B 5/14 300B 300E 300F
Claims (1)
液濾過材料とこれを収容し血液入口と濾過液出口を有す
るホルダーよりなる血液濾過器と、該血液入口にチュー
ブを介して接続された採血針と、該濾過液出口にチュー
ブを介して接続された真空採血管又は注射器よりなる血
漿採取具1. A blood filter material comprising a glass fiber filter paper and a microporous membrane, a blood filter comprising a holder containing the blood filter material and having a blood inlet and a filtrate outlet, and connected to the blood inlet via a tube. A blood collection needle comprising a blood collection needle and a vacuum blood collection tube or syringe connected to the filtrate outlet via a tube
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000120324A JP2001299730A (en) | 2000-04-21 | 2000-04-21 | Plasma collecting instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000120324A JP2001299730A (en) | 2000-04-21 | 2000-04-21 | Plasma collecting instrument |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001299730A true JP2001299730A (en) | 2001-10-30 |
Family
ID=18631151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000120324A Pending JP2001299730A (en) | 2000-04-21 | 2000-04-21 | Plasma collecting instrument |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001299730A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006280912A (en) * | 2005-03-10 | 2006-10-19 | Fuji Photo Film Co Ltd | Puncture needle for blood sampling |
| JP2009039350A (en) * | 2007-08-09 | 2009-02-26 | Hitachi Chem Co Ltd | Blood cell separating material and production method of blood cell separating material |
| JP2010222376A (en) * | 2003-05-21 | 2010-10-07 | Jms Co Ltd | Serum preparation device |
| JP2015509823A (en) * | 2011-11-21 | 2015-04-02 | クリーティービー マイクロテック, インク.Creatv Microtech, Inc. | Polymer microfiltration device, manufacturing method thereof and use of microfiltration device |
| JP2017099947A (en) * | 2013-04-15 | 2017-06-08 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Blood sampling transfer device and blood separation and test execution system |
| JP2020525802A (en) * | 2017-06-26 | 2020-08-27 | メンドーサ, エステバンMENDOZA, Estevan | Sample filter |
| US11175279B2 (en) | 2010-05-03 | 2021-11-16 | Creatv Microtech, Inc. | Polymer microfilters, devices comprising the same, methods of manufacturing the same, and uses thereof |
-
2000
- 2000-04-21 JP JP2000120324A patent/JP2001299730A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010222376A (en) * | 2003-05-21 | 2010-10-07 | Jms Co Ltd | Serum preparation device |
| US8796017B2 (en) | 2003-05-21 | 2014-08-05 | Jms Co., Ltd. | Container for preparing serum and regenerative medical process using the same |
| US8993321B2 (en) | 2003-05-21 | 2015-03-31 | Jms Co., Ltd. | Container for preparing serum and regenerative medical process using the same |
| JP2006280912A (en) * | 2005-03-10 | 2006-10-19 | Fuji Photo Film Co Ltd | Puncture needle for blood sampling |
| JP2009039350A (en) * | 2007-08-09 | 2009-02-26 | Hitachi Chem Co Ltd | Blood cell separating material and production method of blood cell separating material |
| US11175279B2 (en) | 2010-05-03 | 2021-11-16 | Creatv Microtech, Inc. | Polymer microfilters, devices comprising the same, methods of manufacturing the same, and uses thereof |
| US11860157B2 (en) | 2010-05-03 | 2024-01-02 | Creatv Microtech, Inc. | Polymer microfilters, devices comprising the same, methods of manufacturing the same, and uses thereof |
| US9658207B2 (en) | 2011-04-01 | 2017-05-23 | Creatv Microtech, Inc. | Polymer microfiltration devices, methods of manufacturing the same and the uses of the microfiltration devices |
| JP2015509823A (en) * | 2011-11-21 | 2015-04-02 | クリーティービー マイクロテック, インク.Creatv Microtech, Inc. | Polymer microfiltration device, manufacturing method thereof and use of microfiltration device |
| JP2017099947A (en) * | 2013-04-15 | 2017-06-08 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Blood sampling transfer device and blood separation and test execution system |
| JP2020525802A (en) * | 2017-06-26 | 2020-08-27 | メンドーサ, エステバンMENDOZA, Estevan | Sample filter |
| US11946843B2 (en) | 2017-06-26 | 2024-04-02 | Splitrx Llc | Sample filtration device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6659975B2 (en) | Plasma collecting device | |
| JP3685283B2 (en) | Plasma collection tool | |
| US5979669A (en) | Blood filter unit | |
| US6220453B1 (en) | Blood filter unit | |
| JP3898834B2 (en) | Blood continuous filtration device | |
| US6225130B1 (en) | Method of separating serum from whole blood | |
| JP3715123B2 (en) | Blood filtration unit | |
| US6375856B1 (en) | Method of recovering blood filtration residues | |
| JP3990505B2 (en) | Blood component analysis method | |
| JP2001299730A (en) | Plasma collecting instrument | |
| US6280621B1 (en) | Blood filter cartridge with overflow receiver | |
| JP2001321367A (en) | Plasma or serum taking tool | |
| JP3664286B2 (en) | Blood filtration unit | |
| JP3765661B2 (en) | Blood filtration unit | |
| JP3695680B2 (en) | Blood filtration unit | |
| JP3765680B2 (en) | Blood filter | |
| JP2000009726A (en) | Blood filtrate container | |
| JP2001305130A (en) | Multi-specimen blood filtering device | |
| JP3651867B2 (en) | Blood filtration unit | |
| JP2001321366A (en) | Plasma or serum taking tool | |
| JP3651868B2 (en) | Blood filtration unit | |
| JP2001321365A (en) | Plasma or serum taking tool | |
| JP2000180444A (en) | Hemofilter | |
| JPH11295299A (en) | Blood filtering unit | |
| JP2000081432A (en) | Haemofiltration unit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050922 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20061206 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070905 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070910 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080325 |